SJF-0661

N/A

Report date: 2022/05/25 11:21:07
NME

Base Information

Drug NameSJF-0661
Drug Alias NameSJF-0628
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)Small molecules > Heterocyclic drugs
Mechanisms of ActionProteolysis
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTsinghua University
China Registration ClassN/A

Develop Information

Active CompaniesTsinghua University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A